title: Transcriptional regulation of seprase in invasive melanoma cells by transforming growth factor-β signaling.
abstract: The tumor invasive phenotype driven by seprase expression/activity has been widely examined in an array of malignant tumor cell types; however, very little is known about the transcriptional regulation of this critical protease. Seprase (also named fibroblast activation protein-α, antiplasmin-cleaving enzyme, and dipeptidyl prolyl peptidase 5) is expressed at high levels by stromal fibroblast, endothelial, and tumor cells in a variety of invasive tumors but is undetectable in the majority of normal adult tissues. To examine the transcriptional regulation of the gene, we cloned the human seprase promoter and demonstrated that endogenous seprase expression and exogenous seprase promoter activity are high in invasive melanoma cells but not in non-invasive melanoma cells/primary melanocytes. In addition, we identified a crucial TGF-β-responsive cis-regulatory element in the proximal seprase promoter region that enabled robust transcriptional activation of the gene. Treatment of metastatic but not normal/non-invasive cells with TGF-β1 caused a rapid and profound up-regulation of endogenous seprase mRNA, which coincided with an abolishment of the negative regulator c-Ski, and an increase in binding of Smad3/4 to the seprase promoter in vivo. Blocking TGF-β signaling in invasive melanoma cells through overexpression of c-Ski, chemically using SB-431542, or with a neutralizing antibody against TGF-β significantly reduced seprase mRNA levels. Strikingly, RNAi of seprase in invasive cells greatly diminished their invasive potential in vitro as did blocking TGF-β signaling using SB-431542. Altogether, we found that seprase is transcriptionally up-regulated in invasive melanoma cells via the canonical TGF-β signaling pathway, supporting the roles of both TGF-β and seprase in tumor invasion and metastasis.
authors.affiliation: From the Metastasis Research Laboratory, Division of Gynecologic Oncology, Stony Brook Medicine, Stony Brook, New York 11794.
authors.forename: Shaun
authors.initials: S
authors.lastname: Tulley
authors.affiliation: From the Metastasis Research Laboratory, Division of Gynecologic Oncology, Stony Brook Medicine, Stony Brook, New York 11794 Wen-Tien.Chen@stonybrookmedicine.edu.
authors.forename: Wen-Tien
authors.initials: WT
authors.lastname: Chen
mesh_terms: D045744:Cell Line, Tumor; D000078404:Epidermal Cells; D005347:Fibroblasts / Q000166:cytology / Q000201:enzymology; D015971:Gene Expression Regulation, Enzymologic; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D015603:Keratinocytes / Q000166:cytology / Q000201:enzymology; D008544:Melanocytes / Q000166:cytology / Q000201:enzymology; D008545:Melanoma / Q000201:enzymology / Q000235:genetics* / Q000473:pathology; D009361:Neoplasm Invasiveness; D011401:Promoter Regions, Genetic / Q000235:genetics; D012697:Serine Endopeptidases / Q000235:genetics* / Q000378:metabolism*; D015398:Signal Transduction / Q000235:genetics; D012878:Skin Neoplasms / Q000201:enzymology / Q000235:genetics* / Q000473:pathology; D014158:Transcription, Genetic / Q000187:drug effects / Q000502:physiology; D053773:Transforming Growth Factor beta1 / Q000378:metabolism* / Q000494:pharmacology
chemical_list: D053773:Transforming Growth Factor beta1; D012697:Serine Endopeptidases; C478147:seprase, human
keywords: Gene Regulation; Gene Transcription; Invasion; Melanoma; Serine Protease; Transcription Promoter; Transcription Regulation
references.citation: Cell. 2002 Nov 1;111(3):357-67
references.pmid: 12419246
references.citation: J Cell Biol. 1988 Mar;106(3):761-71
references.pmid: 2450098
references.citation: J Cell Biochem. 2006 Aug 15;98(6):1380-90
references.pmid: 16598746
references.citation: Cancer Lett. 2003 Sep 10;199(1):91-8
references.pmid: 12963128
references.citation: Nucleic Acids Res. 1990 Jan 25;18(2):337-43
references.pmid: 2183181
references.citation: Exp Mol Pathol. 2013 Aug;95(1):105-10
references.pmid: 23778090
references.citation: Genes Dev. 1999 Sep 1;13(17):2196-206
references.pmid: 10485843
references.citation: Mol Cell. 1998 Mar;1(4):611-7
references.pmid: 9660945
references.citation: Annu Rev Cell Dev Biol. 2005;21:659-93
references.pmid: 16212511
references.citation: J Cell Physiol. 1999 Feb;178(2):179-87
references.pmid: 10048582
references.citation: Genes Dev. 2005 Dec 1;19(23):2783-810
references.pmid: 16322555
references.citation: Exp Mol Pathol. 2013 Dec;95(3):350-56
references.pmid: 24422232
references.citation: J Biol Chem. 2003 Jul 11;278(28):26249-57
references.pmid: 12732634
references.citation: PLoS One. 2011;6(6):e20758
references.pmid: 21674054
references.citation: Genomics. 1995 Jan 1;25(1):335-7
references.pmid: 7774951
references.citation: Front Biosci (Elite Ed). 2010 Jun 01;2:1154-63
references.pmid: 20515787
references.citation: J Virol. 1998 Nov;72(11):8463-71
references.pmid: 9765382
references.citation: Cytokine Growth Factor Rev. 2006 Feb-Apr;17(1-2):41-58
references.pmid: 16310402
references.citation: J Biol Chem. 1999 Dec 3;274(49):35269-77
references.pmid: 10575014
references.citation: Cancer Immun. 2005 Aug 03;5:10
references.pmid: 16076089
references.citation: Proc Natl Acad Sci U S A. 1990 Sep;87(18):7235-9
references.pmid: 2402505
references.citation: Cell. 2003 Jun 13;113(6):685-700
references.pmid: 12809600
references.citation: Nat Genet. 2001 Oct;29(2):117-29
references.pmid: 11586292
references.citation: J Invest Dermatol. 2003 Feb;120(2):182-8
references.pmid: 12542520
references.citation: Cancer Res. 1991 Sep 15;51(18):4815-20
references.pmid: 1716514
references.citation: Tumour Biol. 2013 Apr;34(2):1013-20
references.pmid: 23328994
references.citation: Eur J Cancer. 2010 May;46(7):1232-40
references.pmid: 20307969
references.citation: Anticancer Res. 1994 Nov-Dec;14(6B):2565-71
references.pmid: 7872682
references.citation: Cancer Res. 2008 May 1;68(9):3277-85
references.pmid: 18451154
references.citation: Biochim Biophys Acta. 2008 Sep;1784(9):1130-45
references.pmid: 18262497
references.citation: Oncology. 2004;67(5-6):411-9
references.pmid: 15713998
references.citation: Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12442-7
references.pmid: 10535941
references.citation: EMBO J. 1998 Jun 1;17(11):3091-100
references.pmid: 9606191
references.citation: Cancer Res. 1986 Dec;46(12 Pt 1):6406-12
references.pmid: 2877731
references.citation: Arthritis Res Ther. 2006;8(1):R23
references.pmid: 16507127
references.citation: J Biol Chem. 1998 Feb 6;273(6):3588-97
references.pmid: 9452486
references.citation: Int J Cancer. 2007 Sep 1;121(5):966-77
references.pmid: 17455258
references.citation: Int J Cancer. 1994 Aug 1;58(3):385-92
references.pmid: 7519584
references.citation: Cell. 2008 Jul 25;134(2):215-30
references.pmid: 18662538
references.citation: J Biol Chem. 2007 Jul 13;282(28):20492-501
references.pmid: 17510063
references.citation: Cancer Res. 1994 Jan 15;54(2):575-81
references.pmid: 8275496
references.citation: J Biol Chem. 2003 Aug 15;278(33):30540-7
references.pmid: 12764135
references.citation: Int J Cancer. 1988 Mar 15;41(3):442-9
references.pmid: 3346110
references.citation: Clin Exp Metastasis. 2011 Aug;28(6):567-79
references.pmid: 21604185
references.citation: Int J Cancer. 2009 Jan 1;124(1):27-35
references.pmid: 18823010
references.citation: J Biol Chem. 1999 Dec 17;274(51):36505-12
references.pmid: 10593948
references.citation: J Biol Chem. 2003 Aug 29;278(35):32489-92
references.pmid: 12857746
references.citation: Chin Med J (Engl). 2007 Apr 20;120(8):663-8
references.pmid: 17517181
references.citation: Oncogene. 2004 Jun 24;23(29):5068-76
references.pmid: 15107821
references.citation: Mod Pathol. 1998 Sep;11(9):855-63
references.pmid: 9758365
references.citation: Proc Natl Acad Sci U S A. 1990 Nov;87(21):8296-300
references.pmid: 2172980
references.citation: Pancreas. 2008 Aug;37(2):154-8
references.pmid: 18665076
references.citation: Biochim Biophys Acta. 1997 Jul 10;1361(1):11-9
references.pmid: 9247085
references.citation: J Surg Oncol. 2013 Sep;108(3):157-62
references.pmid: 23813624
references.citation: J Invest Dermatol. 1991 Jul;97(1):20-6
references.pmid: 2056188
references.citation: J Biol Chem. 1997 Mar 21;272(12):7595-601
references.pmid: 9065413
references.citation: Cancer Lett. 2008 Aug 8;266(2):263-74
references.pmid: 18423981
references.citation: Cancer Res. 1994 Nov 1;54(21):5702-10
references.pmid: 7923219
references.citation: Clin Cancer Res. 2007 Mar 15;13(6):1736-41
references.pmid: 17363526
references.citation: Cancer Res. 2006 Oct 15;66(20):9977-85
references.pmid: 17047060
references.citation: Cancer Res. 1999 Feb 1;59(3):547-50
references.pmid: 9973198
references.citation: Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5657-61
references.pmid: 7911242
references.citation: Anticancer Res. 2003 Jul-Aug;23(4):3195-8
references.pmid: 12926053
references.citation: Ultrastruct Pathol. 2008 May-Jun;32(3):89-96
references.pmid: 18570153
references.citation: Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11400-6
references.pmid: 8876147
references.citation: Exp Mol Pathol. 2009 Dec;87(3):189-94
references.pmid: 19747910